» Articles » PMID: 32247038

Potential Effect of Blood Purification Therapy in Reducing Cytokine Storm As a Late Complication of Critically Ill COVID-19

Overview
Journal Clin Immunol
Date 2020 Apr 5
PMID 32247038
Citations 94
Authors
Affiliations
Soon will be listed here.
Citing Articles

[Therapeutic Options for the Management of Severe COVID-19: A Rheumatology Perspective].

Mendoza-Pinto C, Garcia-Carrasco M, Munguia Realpozo P, Mendez-Martinez S Reumatol Clin. 2024; 17(8):431-436.

PMID: 38620231 PMC: 7229930. DOI: 10.1016/j.reuma.2020.05.002.


Analysis of death risk factors among COVID-19 patients in Yazd, Iran: A case-cohort study.

Mirjalili M, Raadabadi M, Dehghani M, Aliabad M, Mansouri M, Martini M J Prev Med Hyg. 2023; 64(3):E304-E310.

PMID: 38125988 PMC: 10730059. DOI: 10.15167/2421-4248/jpmh2023.64.3.3098.


Correlation of covid-19 and Guillain-Barré syndrome: A Mechanistic Perspective.

Sharma V, Chhabra T, Singh T Obes Med. 2023; 40:100493.

PMID: 37131407 PMC: 10091783. DOI: 10.1016/j.obmed.2023.100493.


Cutaneous Manifestation in COVID-19: A Lesson Over 2 Years Into the Pandemic.

Danarti R, Limantara N, Rini D, Budiarso A, Febriana S, Soebono H Clin Med Res. 2023; 21(1):36-45.

PMID: 37130789 PMC: 10153677. DOI: 10.3121/cmr.2023.1598.


Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now.

Mohammed M Front Pharmacol. 2023; 14:1111329.

PMID: 37124230 PMC: 10134036. DOI: 10.3389/fphar.2023.1111329.


References
1.
Monard C, Rimmele T, Ronco C . Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif. 2019; 47 Suppl 3:1-14. DOI: 10.1159/000499520. View

2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

3.
Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gomez-Puerta J, Ramos-Casals M . Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006; 54(8):2568-76. DOI: 10.1002/art.22018. View

4.
Schwindenhammer V, Girardot T, Chaulier K, Gregoire A, Monard C, Huriaux L . oXiris® Use in Septic Shock: Experience of Two French Centres. Blood Purif. 2019; 47 Suppl 3:1-7. DOI: 10.1159/000499510. View

5.
Xu X, Han M, Li T, Sun W, Wang D, Fu B . Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020; 117(20):10970-10975. PMC: 7245089. DOI: 10.1073/pnas.2005615117. View